Is it necessary to take long-term use during treatment with Veneclatra?
Venetoclax is a targeted therapy drug mainly used to treat hematological malignancies such as chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML). It controls tumor growth by inhibiting BCL-2 protein and promoting the death of tumor cells. Many patients respond well to treatment with venetoclax, but the duration of treatment and whether long-term use is still a concern for patients and doctors.

For most patients treated with venetoclax, treatment is likely to be long-term, but the specific treatment cycles and length of treatment vary among individuals. When treating patients with chronic lymphocytic leukemia (CLL), venetoclax is often used initially in combination with other chemotherapy drugs to form a combination treatment regimen. For some patients, initial treatment may achieve significant results, with a significant reduction in tumor burden or even remission. However, treatment with venetoclax does not necessarily completely cure the disease, so treatment with venetoclax may need to be continued to provide long-term control of the disease and prevent recurrence.
For patients with acute myeloid leukemia (AML), the course of treatment with venetoclax is usually more individualized. AML is a rapidly progressive disease, and treatment plans often need to be adjusted based on the patient's specific condition, genetic mutations, and other treatment responses. Some AML patients may need long-term maintenance therapy after treatment with venetoclax to reduce the risk of relapse. Long-term use of venetoclax can help maintain the effects of treatment and reduce the recurrence and spread of tumor cells.
Long-term use of venetoclax may cause some side effects, including immunosuppression, bone marrow suppression, abnormal liver function, etc. Therefore, patients need to undergo regular medical examinations when taking venetoclax for a long time to ensure that the treatment is safe and effective.
Reference materials:https://www.venclexta.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)